Cargando…
The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma
Chronic asthma is associated with persistent lung inflammation and long-term remodelling of the airways that have proved refractory to conventional treatments such as steroids, despite their efficacy in controlling acute airway contraction and bronchial inflammation. As its recent dramatic increase...
Autores principales: | Coltherd, J. C., Rodgers, D. T., Lawrie, R. E., Al-Riyami, L., Suckling, C. J., Harnett, W., Harnett, M. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725896/ https://www.ncbi.nlm.nih.gov/pubmed/26763929 http://dx.doi.org/10.1038/srep19224 |
Ejemplares similares
-
Drug-like analogues of the parasitic worm-derived immunomodulator ES-62 are therapeutic in the MRL/Lpr model of systemic lupus erythematosus
por: Rodgers, D T, et al.
Publicado: (2015) -
Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties
por: Rzepecka, Justyna, et al.
Publicado: (2014) -
Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens
por: Janicova, L., et al.
Publicado: (2016) -
Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62
por: Lumb, Felicity E., et al.
Publicado: (2017) -
Designing Anti-inflammatory
Drugs from Parasitic Worms:
A Synthetic Small Molecule Analogue of the Acanthocheilonema
viteae Product ES-62 Prevents Development of Collagen-Induced
Arthritis
por: Al-Riyami, Lamyaa, et al.
Publicado: (2013)